2026-04-13T15:10:57Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/2285912026-04-07T22:20:28Zcom_2072_1057col_2072_478861col_2072_478916col_2072_478917

00925njm 22002777a 4500 dc Navarro i Sabaté, Àurea author Font, Rebeca author Espinàs Piñol, Josep Alfons author Solà, Judit author Martínez Soler, Fina author Gil Gil, Miguel author Viñas, Gemma author Tibau Martorell, Ariadna author Borrell, Maria author Segui Palmer, Miguel Ángel author Margelí Vila, Mireia author Servitja, Sonia author Pérez Segura, Cristina author Domènech, M. author Nava, Maria Ángeles author Marin, Mar author Gonzalez, Sergi author Borràs Andrés, Josep Maria author 2026-03-30T12:13:48Z 2026-03-30T12:13:48Z 2025 2026-03-30T12:13:49Z Simple Summary: The objective of this study was to evaluate the validity of RWD-based adherence measurements obtained from accessible electronic health records in the Spanish national health system in all women diagnosed with breast cancer in the public healthcare system in Catalonia (Spain). Our results showed that nonadherence during the first year of treatment was around 11% in both cohorts, analysed using the RWD, and without significant differences between them. Furthermore, determinants associated with nonadherence (age and type of oral endocrine treatment) were similar in both approaches used. The results also show that it is fast and feasible to use RWD to identify individuals who are not refilling prescriptions as often as they should. In conclusion, the validity of the RWD method to estimate adherence has been confirmed and, at the same time, this method provides valuable evidence to help oncologists discuss adherence with their patients. Ressenyes sistemàtiques (Investigació mèdica) Infermeria basada en l'evidència Càncer de mama Systematic reviews (Medical research) Evidence-based nursing Breast cancer Evaluating the quality of real-world data on adherence to oral endocrine therapy in breast cancer patients: How real-world data?